D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 58 Citations 11,161 157 World Ranking 1303 National Ranking 92

Research.com Recognitions

Awards & Achievements

Fellow of the European Confederation of Medical Mycology (ECMM)

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Fungus
  • Microbiology

His scientific interests lie mostly in Microbiology, Caspofungin, Amphotericin B, Mucormycosis and Posaconazole. His research on Microbiology frequently connects to adjacent areas such as Rhizopus microsporus. The study incorporates disciplines such as Corpus albicans, Candida albicans and Echinocandin in addition to Caspofungin.

Within one scientific family, he focuses on topics pertaining to Internal medicine under Mucormycosis, and may sometimes address concerns connected to Lichtheimia corymbifera. His Posaconazole research integrates issues from Acremonium, Amphotericin B deoxycholate and Intensive care medicine. His Surgery research includes themes of Cancer, Liposomal amphotericin, Gastroenterology, Hematology and Skin infection.

His most cited work include:

  • ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013 (543 citations)
  • EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts. (485 citations)
  • ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others (269 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Microbiology, Amphotericin B, Aspergillus fumigatus, Voriconazole and Caspofungin. All of his Microbiology and Itraconazole, Posaconazole, Candida albicans, Aspergillus and Etest investigations are sub-components of the entire Microbiology study. In his study, which falls under the umbrella issue of Posaconazole, Identification is strongly linked to Mucormycosis.

His Flucytosine study in the realm of Amphotericin B interacts with subjects such as Antagonism. His Voriconazole study combines topics in areas such as Internal medicine and In vitro. His Caspofungin research is multidisciplinary, incorporating perspectives in Minimum inhibitory concentration, Echinocandin, Candida spp and Micafungin.

He most often published in these fields:

  • Microbiology (80.97%)
  • Amphotericin B (33.63%)
  • Aspergillus fumigatus (25.66%)

What were the highlights of his more recent work (between 2018-2021)?

  • Microbiology (80.97%)
  • Amphotericin B (33.63%)
  • Mucorales (16.81%)

In recent papers he was focusing on the following fields of study:

Eric Dannaoui mostly deals with Microbiology, Amphotericin B, Mucorales, Antifungal and Aspergillus fumigatus. Aspergillus, Itraconazole, Posaconazole, Broth microdilution and Echinocandins are the subjects of his Microbiology studies. His Amphotericin B study incorporates themes from Multiple drug resistance, Corpus albicans, Candida auris, Voriconazole and Pharmacology.

His work in the fields of Lichtheimia corymbifera overlaps with other areas such as Rhizopus arrhizus. His Antifungal study combines topics from a wide range of disciplines, such as In vitro, Chromatography, Checkerboard, Etest and Agar. His studies deal with areas such as Antibiosis, Antimicrobial, Rifampicin and Biofilm as well as Aspergillus fumigatus.

Between 2018 and 2021, his most popular works were:

  • Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. (121 citations)
  • Invasive fungal diseases during COVID-19: We should be prepared. (50 citations)
  • Prevalence, geographic risk factor, and development of a standardized protocol for fungal isolation in cystic fibrosis: Results from the international prospective study “MFIP” (19 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Fungus
  • Bacteria

Mucorales, Microbiology, In vivo, Caspofungin and Candida auris are his primary areas of study. In general Mucorales study, his work on Lichtheimia corymbifera often relates to the realm of Rhizopus arrhizus, thereby connecting several areas of interest. His works in Rhizomucor, Cryptococcus, Antifungal and Aspergillus are all subjects of inquiry into Microbiology.

In general Caspofungin, his work in Echinocandins is often linked to Context linking many areas of study. His Candida auris research includes elements of Flucytosine, Multiple drug resistance and Voriconazole, Micafungin. His Micafungin study is concerned with the larger field of Amphotericin B.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts.

J.L. Rodriguez-Tudela;M.C. Arendrup;F. Barchiesi;J. Bille.
Clinical Microbiology and Infection (2008)

751 Citations

ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013

O.A. Cornely;S. Arikan-Akdagli;E. Dannaoui;A.H. Groll.
Clinical Microbiology and Infection (2014)

543 Citations

A Global Analysis of Mucormycosis in France: The RetroZygo Study (2005–2007)

F. Lanternier;F. Lanternier;F. Lanternier;E. Dannaoui;E. Dannaoui;E. Dannaoui;G. Morizot;C. Elie.
Clinical Infectious Diseases (2012)

369 Citations

Sequence-Based Identification of Aspergillus, Fusarium, and Mucorales Species in the Clinical Mycology Laboratory: Where Are We and Where Should We Go from Here?

S. A. Balajee;A. M. Borman;M. E. Brandt;J. Cano.
Journal of Clinical Microbiology (2009)

368 Citations

Increasing incidence of zygomycosis (mucormycosis), France, 1997-2006.

Dounia Bitar;Dieter Van Cauteren;Fanny Lanternier;Eric Dannaoui.
Emerging Infectious Diseases (2009)

354 Citations

In vitro susceptibilities of zygomycetes to conventional and new antifungals

Eric Dannaoui;Joseph Meletiadis;Johan W Mouton;Jacques F G M Meis.
Journal of Antimicrobial Chemotherapy (2003)

326 Citations

ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others

A.M. Tortorano;M. Richardson;E. Roilides;A. van Diepeningen.
Clinical Microbiology and Infection (2014)

307 Citations

Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus.

J W M van der Linden;M C Arendrup;A Warris;Katrien Lagrou.
Emerging Infectious Diseases (2015)

263 Citations

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi

A. Chowdhary;J. F. Meis;J. Guarro;G. S. de Hoog.
Clinical Microbiology and Infection (2014)

211 Citations

Molecular Identification of Zygomycetes from Culture and Experimentally Infected Tissues

Patrick Schwarz;Stéphane Bretagne;Jean-Charles Gantier;Dea Garcia-Hermoso.
Journal of Clinical Microbiology (2006)

203 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Eric Dannaoui

Jacques F. Meis

Jacques F. Meis

Canisius-Wilhelmina Ziekenhuis

Publications: 112

Maiken Cavling Arendrup

Maiken Cavling Arendrup

Statens Serum Institut

Publications: 112

Manuel Cuenca-Estrella

Manuel Cuenca-Estrella

Instituto de Salud Carlos III

Publications: 111

Paul E. Verweij

Paul E. Verweij

Radboud University Nijmegen

Publications: 109

Olivier Lortholary

Olivier Lortholary

Université Paris Cité

Publications: 108

Dimitrios P. Kontoyiannis

Dimitrios P. Kontoyiannis

The University of Texas MD Anderson Cancer Center

Publications: 78

Oliver A. Cornely

Oliver A. Cornely

University of Cologne

Publications: 71

David S. Perlin

David S. Perlin

Rutgers, The State University of New Jersey

Publications: 70

Josep Guarro

Josep Guarro

Rovira i Virgili University

Publications: 70

Thomas J. Walsh

Thomas J. Walsh

Weill Cornell Medicine

Publications: 67

Sharon C.-A. Chen

Sharon C.-A. Chen

University of Sydney

Publications: 65

Jesús Guinea

Jesús Guinea

Hospital General Universitario Gregorio Marañón

Publications: 61

Teun Boekhout

Teun Boekhout

University of Amsterdam

Publications: 60

Stéphane Bretagne

Stéphane Bretagne

Université Paris Cité

Publications: 56

Michael A. Pfaller

Michael A. Pfaller

JMI Laboratories

Publications: 55

Ashraf S. Ibrahim

Ashraf S. Ibrahim

University of California, Los Angeles

Publications: 50

Trending Scientists

Ning Zhang

Ning Zhang

University of Windsor

William F. Hunt

William F. Hunt

North Carolina State University

Kurt Polborn

Kurt Polborn

Ludwig-Maximilians-Universität München

Konstantin P. Bryliakov

Konstantin P. Bryliakov

Novosibirsk State University

Nancy E. Levinger

Nancy E. Levinger

Colorado State University

Jeong-Myeong Ha

Jeong-Myeong Ha

Korea Institute of Science and Technology

Seng H. Cheng

Seng H. Cheng

Pfizer (United States)

Jukka Laine

Jukka Laine

University of Helsinki

Peter J. Cripps

Peter J. Cripps

University of Liverpool

Thomas S. Whittam

Thomas S. Whittam

Michigan State University

Michael A. Curtis

Michael A. Curtis

King's College London

John H. Jones

John H. Jones

University of Arizona

Susan D. Hovorka

Susan D. Hovorka

The University of Texas at Austin

Daniel R. Ilgen

Daniel R. Ilgen

Michigan State University

Debra A. Murphy

Debra A. Murphy

University of California, Los Angeles

Byron Egeland

Byron Egeland

University of Minnesota

Something went wrong. Please try again later.